Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment

In developed countries, endometrial cancer (EC) is one of the most common neoplasms of the female reproductive system. MicroRNAs (miRs) are a class of single-stranded noncoding RNA molecules with lengths of 19–25 nucleotides that bind to target messenger RNA (mRNA) to regulate post-transcriptional g...

Full description

Bibliographic Details
Main Authors: Sergio Antonio Oropeza-de Lara, Idalia Garza-Veloz, Bertha Berthaud-González, Margarita L. Martinez-Fierro
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/10/2686
_version_ 1797600705463189504
author Sergio Antonio Oropeza-de Lara
Idalia Garza-Veloz
Bertha Berthaud-González
Margarita L. Martinez-Fierro
author_facet Sergio Antonio Oropeza-de Lara
Idalia Garza-Veloz
Bertha Berthaud-González
Margarita L. Martinez-Fierro
author_sort Sergio Antonio Oropeza-de Lara
collection DOAJ
description In developed countries, endometrial cancer (EC) is one of the most common neoplasms of the female reproductive system. MicroRNAs (miRs) are a class of single-stranded noncoding RNA molecules with lengths of 19–25 nucleotides that bind to target messenger RNA (mRNA) to regulate post-transcriptional gene expression. Although there is a large amount of research focused on identifying miRs with a diagnostic, prognostic, or response to treatment capacity in EC, these studies differ in terms of experimental methodology, types of samples used, selection criteria, and results obtained. Hence, there is a large amount of heterogeneous information that makes it difficult to identify potential miR biomarkers. We aimed to summarize the current knowledge on miRs that have been shown to be the most suitable potential markers for EC. We searched PubMed and Google Scholar without date restrictions or filters. We described 138 miRs with potential diagnostic, prognostic, or treatment response potential in EC. Seven diagnostic panels showed higher sensitivity and specificity for the diagnosis of EC than individual miRs. We further identified miRs up- or downregulated depending on the FIGO stage, precursor lesions, and staging after surgery, which provides insight into which miRs are expressed chronologically depending on the disease stage and/or that are modulated depending on the tumor grade based on histopathological evaluation.
first_indexed 2024-03-11T03:52:41Z
format Article
id doaj.art-5ef33fc6916849e78f753560eef630e5
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T03:52:41Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-5ef33fc6916849e78f753560eef630e52023-11-18T00:47:30ZengMDPI AGCancers2072-66942023-05-011510268610.3390/cancers15102686Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to TreatmentSergio Antonio Oropeza-de Lara0Idalia Garza-Veloz1Bertha Berthaud-González2Margarita L. Martinez-Fierro3Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Universidad Autónoma de Zacatecas, Carretera Zacatecas-Guadalajara Km 6, Ejido La Escondida, Zacatecas 98160, MexicoMolecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Universidad Autónoma de Zacatecas, Carretera Zacatecas-Guadalajara Km 6, Ejido La Escondida, Zacatecas 98160, MexicoHospital General Zacatecas “Luz González Cosío”, Servicios de Salud de Zacatecas, Zacatecas 98160, MexicoMolecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Universidad Autónoma de Zacatecas, Carretera Zacatecas-Guadalajara Km 6, Ejido La Escondida, Zacatecas 98160, MexicoIn developed countries, endometrial cancer (EC) is one of the most common neoplasms of the female reproductive system. MicroRNAs (miRs) are a class of single-stranded noncoding RNA molecules with lengths of 19–25 nucleotides that bind to target messenger RNA (mRNA) to regulate post-transcriptional gene expression. Although there is a large amount of research focused on identifying miRs with a diagnostic, prognostic, or response to treatment capacity in EC, these studies differ in terms of experimental methodology, types of samples used, selection criteria, and results obtained. Hence, there is a large amount of heterogeneous information that makes it difficult to identify potential miR biomarkers. We aimed to summarize the current knowledge on miRs that have been shown to be the most suitable potential markers for EC. We searched PubMed and Google Scholar without date restrictions or filters. We described 138 miRs with potential diagnostic, prognostic, or treatment response potential in EC. Seven diagnostic panels showed higher sensitivity and specificity for the diagnosis of EC than individual miRs. We further identified miRs up- or downregulated depending on the FIGO stage, precursor lesions, and staging after surgery, which provides insight into which miRs are expressed chronologically depending on the disease stage and/or that are modulated depending on the tumor grade based on histopathological evaluation.https://www.mdpi.com/2072-6694/15/10/2686endometrial cancermiRNAsbiomarkersdiagnosisprognosisresponse to treatment
spellingShingle Sergio Antonio Oropeza-de Lara
Idalia Garza-Veloz
Bertha Berthaud-González
Margarita L. Martinez-Fierro
Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment
Cancers
endometrial cancer
miRNAs
biomarkers
diagnosis
prognosis
response to treatment
title Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment
title_full Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment
title_fullStr Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment
title_full_unstemmed Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment
title_short Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment
title_sort circulating and endometrial tissue microrna markers associated with endometrial cancer diagnosis prognosis and response to treatment
topic endometrial cancer
miRNAs
biomarkers
diagnosis
prognosis
response to treatment
url https://www.mdpi.com/2072-6694/15/10/2686
work_keys_str_mv AT sergioantoniooropezadelara circulatingandendometrialtissuemicrornamarkersassociatedwithendometrialcancerdiagnosisprognosisandresponsetotreatment
AT idaliagarzaveloz circulatingandendometrialtissuemicrornamarkersassociatedwithendometrialcancerdiagnosisprognosisandresponsetotreatment
AT berthaberthaudgonzalez circulatingandendometrialtissuemicrornamarkersassociatedwithendometrialcancerdiagnosisprognosisandresponsetotreatment
AT margaritalmartinezfierro circulatingandendometrialtissuemicrornamarkersassociatedwithendometrialcancerdiagnosisprognosisandresponsetotreatment